Drug class
Endogenous pancreatic peptide hormone; amylin (islet amyloid polypeptide)
Mechanism of action
Amylin is co-secreted with insulin by pancreatic beta cells. It reduces postprandial glucagon secretion, slows gastric emptying and promotes satiety through amylin-receptor signalling. Amlintide is an entry term for the endogenous hormone, not the marketed analogue pramlintide.
General use cases
- Endogenous physiological hormone rather than a conventional marketed API. The pharmacological actions of amylin are relevant to pramlintide and investigational amylin analogues; do not assign pramlintide indications to native amylin.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
